Tate & Lyle (TATE) CMD 2025 summary

Strategic transformation and growth focus

• Completed transformation into a specialty food and beverage solutions business, highlighted by the integration of CP Kelco, shifting away from commodities and focusing on innovation, solution selling, and higher-margin categories.

• Portfolio reshaping and four strategic acquisitions since 2018 have positioned the business for accelerated growth, with a unique portfolio and scientific expertise in sweetening, mouthfeel, and fortification.

• Accelerated investment in R&D, innovation, and customer-facing capabilities, including the launch of ALFIE, an automated lab for rapid ingredient experimentation.

• Expanded global footprint with 21 customer collaboration centers, focusing on high-growth regions such as Asia, Middle East, Africa, and Latin America, with over 70% in fast-growing markets.

• Purpose-driven approach centers on transforming lives through food science, supporting healthy living, thriving communities, and environmental care.

Financial guidance and operational performance

• Specialty business now generates £2.1 billion in revenue with a 21% EBITDA margin, benchmarking well against peers, and EBITDA margin improved from 17.4% in 2020 to 21% in 2025.

• Medium-term financial algorithm targets organic revenue growth of 4%-6% per year, with EBITDA and EPS growth ahead of revenue, supported by operational leverage and cost synergies.

• Free cash flow conversion expected to exceed 75%, with over £700 million free cash flow in five years and leverage maintained within 1x-2.5x net debt/EBITDA.

• Integration of CP Kelco expected to deliver $50 million in cost synergies by end of 2027 and 10% revenue synergies over the medium term.

• Capital allocation framework prioritizes organic growth, acquisitions, dividends, and returning surplus capital, with a progressive dividend policy.

Business developments and innovation

• CP Kelco brings market leadership in pectin and specialty bio-gums, expanding the mouthfeel platform and enabling unique solutions for reformulation and clean label trends.

• Enhanced ability to cross-sell and build direct customer relationships, with early wins in cross-selling and a growing pipeline of customer projects.

• 63 new products launched from 2020–2025, with new product revenue growing at a 14% CAGR and now representing 18% of Food & Beverage Solutions revenue, with a combined pipeline worth $430 million.

• ALFIE lab enables 10x faster ingredient development, supporting rapid customer solution delivery and global collaboration.

• Addressable market for its three platforms is c.US$20bn, with substantial opportunity in sugar replacement and core categories like beverage, dairy, soups, sauces, dressings, bakery, and snacks.